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Objectives: To review the number and characteristics of self-reported sleep measures used to evaluate
impaired sleep/wakefulness in traumatic brain injury (TBI) populations.
Methods: We conducted a comprehensive peer-reviewed literature search of Medline, Embase, PsycINFO,
CINAHL, and various bibliographies. Only standardized self-report measures for evaluating sleep
dysfunction and its signs were taken into consideration.
Results: Sixteen self-report measures used in TBI research and clinical practices were identiﬁed. Five were
generic, ﬁve symptom-related, and six were condition-speciﬁc measures. The Pittsburgh sleep quality
index and Epworth sleepiness scale were partially validated in post-acute TBI.
Conclusion: Although no instrument has been speciﬁcally developed for TBI patients, there are scientiﬁc
beneﬁts to using the existing measures. However, additional research is needed to examine their
applicability to the TBI population. The design and introduction of a new instrument able to triage sleep-
related complaints between depressive, other medical, and primary sleep disordersdwith a section for
caregiver reportsdmight assist in the identiﬁcation of the etiology of sleep dysfunction in persons with
TBI. In choosing or developing a sleep measure, researchers and clinicians must consider the speciﬁc
domains they want to screen, diagnose, or monitor. Polysomnography is recommended for diagnosing
speciﬁc sleep disorders that cannot be diagnosed solely using a self-report measure.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
Traumatic brain injury (TBI) is a major global health problem.
According to the World Health Organization, TBI will surpass many
diseases as the major cause of death and disability by the year
2020.1 With an estimated 10 million people affected annually by
TBI, the burden of mortality and morbidity that this condition im-
poses on society makes it a pressing public health concern.
Recently, there has been growing interest in sleep/wake dis-
turbances, with numerous studies published reporting on sleep
problems in patients who sustained a TBI.2e8 According to a recent
systematic review,9 research has shown that patients present a
number of different sleep and wakefulness symptoms, including
an acute or chronic inability to sleep adequately at night
(insomnia10), chronic fatigue,11,12 sleepiness,3 circadian rhythm
disturbances,10 and behavioral manifestations associated with
sleep itself. The recognition of the importance of systematically8; fax: þ1 416 946 8570.
. Mollayeva).
-NC-ND license.assessing sleep difﬁculties in a TBI population has inﬂuenced clin-
ical practice and research in the ﬁeld of TBI. This reﬂects clinicians’
concerns of how there should be better evaluations and treatments
for people with TBI who report signiﬁcant disturbances in sleep/
wake cycles post-injury.
Researchers and clinicians have analyzed sleep using both sub-
jective and objective tools. The former are generally questionnaires
completed by subjects; the latter are techniques such as poly-
somnography (PSG),13 actigraphy,14 the multiple sleep latency test
(MSLT)15 and the maintenance of wakefulness test (MWT).16 PSG
evaluates the nocturnal sleep structure by quantifying sleep distur-
bances. The MSLT quantiﬁes daytime sleepiness. Finally, the MWT
evaluates a person’s ability to remain alert (i.e., it is a wakefulness
test). Unfortunately, these tests are costly and currently require a
specialized hospital or sleep clinic setting. In addition, they may not
adequately capture the ﬂuctuating nature of some sleep disorders
such as insomnia and circadian rhythm sleep disorders. Furthermore,
PSG results might be inﬂuenced by the ﬁrst night effect, or the alter-
ation of the sleep structure as a result of being in an unfamiliar
environment. Actigraphy is another objective method that has been
Abbreviations
BSIQ Brock sleep and insomnia questionnaire
CBT cognitive behavioral therapy
DSM-IV diagnostic and statistical manual of mental disorders,
4th edition
DII diagnostic interview for insomnia
DBAS dysfunctional beliefs and attitudes about sleep scale
EDS excessive daytime sleepiness
ESS Epworth sleepiness scale
FSS fatigue severity scale
GCS Glasgow coma scale
ISI insomnia severity index
ICSD international classiﬁcation of sleep disorders
LSEQ Leeds sleep evaluation questionnaire
LOC loss of consciousness
MWT maintenance of wakefulness test
MOS sleep scale medical outcomes study sleep scale
mTBI mild traumatic brain injury
MEQ morningness-eveningness questionnaire
MAF multidimensional assessment of fatigue
MFI-20 multidimensional fatigue inventory
MSLT multiple sleep latency test
PLM periodic leg movements
PLMD periodic limb movement disorder
PSQI Pittsburg sleep quality index
PSG polysomnography
PTA post-traumatic amnesia
RBD REM behavior disorder
SDQ sleep disorders questionnaire
SWD sleep-wake disturbance
SSS Stanford sleepiness scale
SNS Swiss narcolepsy scale
TBI traumatic brain injury
UNS Ullanlinna narcolepsy scale
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can conveniently recordpeople’s activity/inactivity periodsup to 24h
a day over long periods (i.e., weeks or months). Although actigraphs
provide useful collateral measures of sleep patterns, especially when
the patient’s own report is in question,14 they have been found to be
less reliable in distinguishing between quietwakefulness and sleep.17
Discrepancies between these subjective and objective measures18
raise the question as to which type of data is more important: sub-
jective reports of quality of sleep and daytime sleepiness/alertness or
objectiveevaluationreports.Manyresearchersarenowusingpatient-
report scales in assessing sleep, as they believe that self-perceived
health outcomes are more signiﬁcant and of greater relevance to
the patients’ treatment than objective data. Although it may not be
accurate, especially in the TBI population where sleep state misper-
ception is common, questionnaires are often the instruments ﬁrst
used to assess sleep. This is partly because of their cost effectiveness,
their ability to capture unique patient experiences, and the added
privacy during completion, which can enhance the validity of the
responses. Thus, it is necessary and timely to provide a systematic
consideration, solid description, and in-depth understanding of the
strengths and limitations of the whole range of self-reported mea-
surements utilized in the assessment of sleep dysfunction in TBI
research and clinical practice.
Objectives
The purpose of this review was:
1. To identify and comprehensively assess a variety of the existing
self-report sleep measures that have been used to evaluate
impaired sleep andwakefulness in adults with TBIs in the acute
and chronic stages.
2. To examine these instruments’ psychometric properties when
tested in the TBI population.
3. To outline the strengths and weaknesses of self-report sleep
measures when applied to the TBI population.
Methods
Types of studies
All studies focusing on the TBI adult population and that used a
standardized patient-report sleepmeasurewere considered for this
review.Search methods for identiﬁcation of studies
A comprehensive search strategy was performed to identify all
relevant studies, using electronic databases as well as manual se-
lection from relevant bibliographies. The following electronic data-
bases were screened for updated results as of July 2, 2011: Medline
and PsycINFO (1980 to present), CINAHL (1982 to present) and
Embase (1988e2011, week 31). Furthermore, the reference lists of
relevant review articles were scanned for published studies that
may have been missed by the electronic literature search.
The inclusion criteria were:
 Published, peer-reviewed studies in English that included data
on adult subjects with TBI.
The exclusion criteria were:
 Studies that focused on a different topic (e.g., quality of life,
fatigue).
 Studies that used measures speciﬁcally created for one study
only or studies that used adapted measures.
 Letters to editors, reviews without data, case reports, technical
reports, or unpublished manuscripts.
Search terms
Under the supervision of an expert librarian, the following key
search termswereused: “exp sleep*” or “sleepdisorders” alongwith
“exp brain injuries,” “craniocerebral trauma,” “coma, post-head
injury,” “head injuries, penetrating,” “intracranial hemorrhage,
traumatic,” or “exp skull fractures”; to this, we added “question-
naires,” “self report,” “survey,” “exp data collection,” “tool,” “scale,”
“test,” or “exp weights and measures”; ﬁnally, we added, to some
combination of the above, “exp reproducibility of results,” “reli-
ability,” or “validity.” Appropriate truncations were included. The
above search strategy was used only for Embase. For Medline,
PsycINFO, and CINAHL, this strategy was slightly altered (Table S1).
Selection of studies and data abstraction
The abstracts and full articles (when abstracts were not avail-
able) were thoroughly screened by two independent reviewers in
order to ascertain that a self-reported sleep measure had been used
in each study. Furthermore, the full texts of all selected articles
T. Mollayeva et al. / Sleep Medicine Reviews 17 (2013) 411e423 413were reviewed by the same two independent reviewers for the
study purpose when a relevant self-report measure was identiﬁed.
Measures that met our criteria (i.e., standardized, not modiﬁed,
main focus on sleep) were extracted for further analysis. Differ-
ences of opinion were resolved by discussion. A third reviewer was
consulted where consensus could not be reached.
For the assessment of inter-rater reliability, the two reviewers
individually performed independent in-depth reviews and
completed the review forms. The review forms focused on study
design, study population, issues related to the instruments used,
item omission rates, measurement issues, analysis, and quality
appraisal. Results were presented at a meeting and the merit of
each study was discussed. Decisions were made following a full
discussion and in the presence of the third reviewer. In one case,
the decision to include partial results from the study by Masel
et al.19 (e.g., validation of the Epworth sleepiness scale (ESS) and the
Pittsburgh sleep quality index (PSQI) against MSLT) was based on
the study’s use of a scientiﬁcally acceptable method for assessing
the psychometric properties of the instrument, despite that not
being their main purpose. In this case, the third reviewer was
consulted.
Quality assessment
The criteria for evidence-based assessment proposed by Holm-
beck et al.20 were used to provide an “evidence-based assessment
classiﬁcation” for each of the measures reviewed (Table 1). The
following evidence-based categories were proposed: 1) well-
established assessment, 2) approaching well-established assess-
ment, and 3) promising assessment.
Categorization of self-report measures
Instruments for measuring health-related outcomes were
grouped into the following categories: 1) condition-speciﬁc ques-
tionnaires, developed or validated for persons with a speciﬁc health
condition; 2) generic instruments, designed to differentiate be-
tween health conditions; and 3) symptom-related instruments that
screen for signs and symptoms.4
Descriptive aspects of sleep measures
The descriptive aspects were meant to illustrate the design,
content, and possible application of the measures. The following
features of self-report sleep measures were reported: general
characteristics, purpose/content, method of administration,
administration and respondent burden, language (availability of
translations), psychometric properties, strengths, and cautions for
application in a TBI population (Table S2).
Results
Literature search
Theabstractsof studies (N¼366)publishedbefore July2,2011were
retrieved fromMedline (n¼ 176), Embase (n¼ 38), PsycINFO (n¼ 14),
and CINAHL (n¼ 139). We completed a full text review for 54 articles;
following this, we excluded 26 articles, four of which were not peer-
reviewed and 22 of which did not meet the inclusion criteria (Fig. 1).
From these 28 studies included in the ﬁnal analysis, 16 self-
report measures were identiﬁed (Table 2). Each measure was
extracted from the original article, downloaded from the Internet,
or an attempt was made to obtain the instrument from its au-
thor(s). After a review of the measures, organization by type of
measure was completed (Table 3). Of the 16 sleep measuresidentiﬁed, ﬁve were generic in nature (one generic, one quality of
sleep, one chronotype, one diagnostic, and one functioning), ﬁve
were symptom-related (two sleepiness, three fatigue) and six were
condition-speciﬁc measures (four for insomnia and two for nar-
colepsy). An additional literature search was carried out to search
for key terms in the PubMed database on the psychometric prop-
erties of the measures that we extracted.
Study descriptions
Of the ﬁnal 28 studies, two featured participants from acute care
hospitals, nine from inpatient/outpatient rehabilitation settings,
and the rest from community settings (Table 1). The most
commonly utilized scales were the Pittsburgh sleep quality index
(PSQI) and the Epworth sleepiness scale (ESS; 12 studies); the less
frequently used ones were the fatigue severity scale (FSS; 5
studies), the morningnesseeveningness questionnaire (MEQ), and
the insomnia severity index (ISI; 4 studies). The sleep disorders
questionnaire (SDQ), the Swiss narcolepsy scale (SNS), the Ullan-
linna narcolepsy scale (UNS), the multidimensional fatigue in-
ventory (MFI-20), and the multidimensional assessment of fatigue
(MAF) were used in two studies each. The Leeds sleep evaluation
questionnaire (LSEQ), the medical outcome scale for sleep (MOS
sleep scale), the Brock sleep and insomnia questionnaire (BSIQ), the
dysfunctional beliefs and attitudes about sleep scale (DBAS), the
diagnostic interview for insomnia (DII), and the Stanford sleepiness
scale (SSS) were utilized in one study each (Table 1). The sample
size varied from 921 TBI patients to 687.22 In half of the studies, the
sample size did not exceed 50. Some studies had subjects with only
mild TBI,10,21e24 one focused on subjects with severe TBI,12 and the
remainder featured subjects with varying severities of injury. The
mean time from the occurrence of the injury ranged from 2.6
months11 to 94.3 months.25 Moreover, variability was found in the
age and gender of the participants across studies. The mean age of
the study subjects ranged from 21.421 to 51.3725 with the average
age among all samples being 35 y of age. The number of men
exceeded that of women in all studies, with the percentage of men
ranging from 54%26 to 93%.24
Twenty-four5,6,8e12,19e23,25,27e39 of the 28 studies aimed to
describe sleep dysfunction in the TBI population or discriminate
people with sleep disturbances from those with normal sleep pat-
terns. The remaining four studies evaluated effectiveness of treat-
ment interventions.24,26,40,41 Two of the 28 studies focused on the
psychometric evaluation of self-report measures in a TBI popula-
tion19,30 (Table 2). Fichtenberg et al.30 reported on the validity of the
PSQI in a sub-acute TBI sample of 50 patients in distinguishing par-
ticipants with insomnia according to DSM-IV criteria.30 The overall
rate of agreement of the PSQI with DSM-IV diagnosiswas found to be
94%, with a sensitivity of 100% and speciﬁcity of 96%.When the PSQI-
derived calculations of sleep-onset latency, sleep duration, and sleep-
efﬁciencywere comparedwith a sleep diary, meanpaired differences
were small and Pearson correlation coefﬁcients ranged from 0.633 to
0.796 (p < 0.05). The proposed global PSQI cut-off score of 8 was
found to be able to distinguish 96% of insomnia cases correctly, and a
cut-off score of 9 distinguished 98%. The concurrent validity of the
PSQI and the ESS was also reported in a study by Masel et al.19; this
study investigated ESS and PSQI scores and their relationships to the
mean scores on the MSLT in 71 TBI patients 3e27 y post-injury.
Masel et al. found a nonsigniﬁcant correlation between the self-
report scores and the mean MSLT sleep latency.
Measure descriptions
The majority of the measures reviewed, with the exception of
the SDQ, DBAS, DII, SNS, and UNS, are available online and hence
Table 1
Quality assessment in accordance with the evidence-based assessment proposed by Holmbeck et al.20
# Questionnaires Frequency of use by different
investigators
Frequency of use by same investigatorsb Details for critical evaluation/replication Reliabilitya Validitya
Generic measures
1. Leeds sleep evaluation
questionnaire (LSEQ)
1; Lee et al.41 þ. No cost; can be obtained online at: http://www.
epgonline.org/documents/insomnia/leeds-sleep-
evaluation-questinaire.pdf
e e
2. Medical outcome for sleep
(MOS sleep scale)
1; Rao et al.36 þ. No cost; can be obtained online at: http://www.
rand.org/content/dam/rand/www/external/health/
surveys_tools/mos/mos_sleep_survey.pdf
e e
3. Morningness-eveningness
questionnaire (MEQ)
2; Ayalon et al.10 3 by one team; Parcell et al.7;
Shekleton et al.37; Steele et al.38
þ. Can be obtained and completed online at: http://
www.cet-surveys.org/Dialogix/servlet/Dialogix?
schedule¼3&DIRECTIVE¼START
e e
4. Sleep disorders
questionnaire (SDQ)
2; Guilleminault et al.32;
Williams et al.21
e e. Not available to public: Contact e Alan B. Douglass,
M.D., Psychiatry Department, Room 2951 CFOB, University
of Michigan, Ann Arbor, MI 48109e0704, U.S.A.
e e
5. Pittsburgh sleep quality
index (PSQI)
9; Bloomﬁeld et al.39;
Gosselin et al.23;
Kraus et al.22; Mahmood
et al.5;
Masel et al.19; Williams
et al.21
3 by one team; Fichtenberg et al.29;
Fichtenberg et al.30; Fichtenberg
et al.31
þ. Can be obtained online at: http://www.sleep.pitt.edu/
includes/showFile.asp?ﬂtype¼doc&ﬂID¼2532
e Sensitivity e 83e93%; speciﬁcity e
100% (dx of insomnia) for sleep
diary sleep variables: r ¼ 0.64e0.80
(Fichtenberg et al.30); for MSLT:
r ¼ 0.07 (Masel et al.19)
2 by one team; Parcell et al.7;
Shekleton et al.37
2 by one team; Bushnik et al.11;
Englander et al.28
Condition-speciﬁc measures
6. Brock sleep and insomnia
questionnaire (BSIQ)
Williams et al.21 e. Not available to public: To obtain BSIQ, must contact
author Dr. Kimberly Cote: kcote@brocku.ca
e e
7. Dysfunctional beliefs and
attitudes about sleep
scale (DBAS)
Ouellet et al.26 e. Not available to public: For information regarding
obtaining the DBAS, etc contact author C.M. Morin:
cmorin@psy.ulaval.ca
e e
8. Insomnia severity
index (ISI)
2; Bloomﬁeld et al.39 3 by one team; Ouellet et al.6;
Ouellet et al.34; Ouellet et al.26
þ. No cost; can be obtained online at: http://www.
mytherapysession.com/PDFs/InsomniaSeverityIndex.pdf
e e
9. Diagnostic interview for
insomnia (DII)
Ouellet et al.26 e. Not available to public: For information regarding
obtaining interview questions, etc. contact author C.M.
Morin: cmorin@psy.ulaval.ca
e e
10. Swiss narcolepsy scale
(SNS)
e 2 by one team; Baumann et al.27;
Kempf et al.33
e
Not available to public: Those interested in using the
measure should contact: Prof. Claudio L. Bassetti,
Neurologische Universitatspoliklinik, Universitatsspital
Zurich, Fraeunklinikstrasse 26, Zurich 8091, Switzerland.
Fax: þ41 255 4649; email: Claudio.bassetti@usz.ch
e e
11. Ullanlinna narcolepsy scale
(UNS)
e 2 by one team; Baumann et al.27;
Kempf et al.33
e. Not available to public: Those interested in using the
instrument must contact: Christer Hublin MD, Department
of Neurology, University of Helsinki, Haartmanink. 4,
SF-00290 Helsinki, Finland. Fax þ358/04714009
e e
Symptom-related measures
12. Epworth sleepiness
scale (ESS)
9; Chaumet et al.12;
Fichtenberg et al.30;
Gosselin et al.23;
Guilleminault et al.32;
Lee et al.41; Ruff
et al.24
3x by one team; Parcell et al.35;
Parcell et al.7; Shekleton et al.37
þ. No cost; can be obtained online at: http://
barrythompsonmd.com/wp-content/uploads/2009/
10/Epworth-Sleepiness-Scale.pdf
e for MSLT: r ¼ 0.16
(Masel et al.19)
2 by one team; Kaiser et al.40;
Kempf et al.33
2 by one team; Masel et al.19;
Wilde et al.25
13. Stanford sleepiness
scale (SSS)
1 Guilleminault et al.32 þ. Can be obtained online at: http://www.stanford.edu/w
dement/sss.html
e e
14. Fatigue severity scale (FSS) 3; Chaumet et al.12 2 by one team; Kaiser et al.40;
Kempf et al.33;
þ. No cost; can be obtained online at: http://www.mult-
sclerosis.org/fatigueseverityscale.html
e e
2 by one team; Bushnik et al.11;
Englander et al.28
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Identified studies from the databases using keywords and 
works cited from relevant articles (N = 366): Medline
(n = 175), Embase (n = 38), PsycINFO (n = 14), 
CINAHL (n 139)
Excluded after reading titles, abstracts, and 
full text for those for which decision 
could not be made by reading title or 
abstract (N = 254): Medline (n = 
132), Embase (n = 17), PsycINFO (n 
= 9), CINAHL (n = 96)
Remaining articles (N = 112)
Exclude duplicate articles (N = 58)
Remaining articles (N = 54), full text review
Exclude articles that are not peer reviewed 
(N = 4)
Remaining articles (N = 50)
Exclude articles that did not meet inclusion 
criteria (N = 22)
Remaining articles identified for inclusion in review (N = 28)
Fig. 1. . Flow diagram for selection of studies.
T. Mollayeva et al. / Sleep Medicine Reviews 17 (2013) 411e423 415accessible by the public. The reporting period for sleep evaluation
varies across themeasures. The LSEQ, MEQ, DBAS, SNS, UNS, and DII
do not have a recall period speciﬁed; the MFI uses the timeline
“lately,” the SSS uses “present,” and the ESS refers to “recent times”;
furthermore, the FSS refers to the past week; the ISS, to the past two
weeks; theMOS and SDQ, to the previous four weeks; and the PSQI,
to the previous month. The number of items ranges from a single
item (SSS) to 175 items (SDQ), most having between 7 and 20 items.
The format of response options varies greatly across all measures.
The majority of the instruments were developed in English and
some subsequently translated into other languages (Tables S3eS5).
Fatigue measures
When reviewing the self-report measures for the assessment of
sleep dysfunction post-TBI, we noted that excessive daytime
sleepiness is a symptom that requires major scientiﬁc and clinical
attention due to its association with several serious medical con-
ditions. The consensus among sleep researchers and clinicians was
Table 2
Peer-reviewed publications addressing sleep dysfunction and its marks in TBI population; the self-report sleep measures used in these studies are listed.
Authors TBI sample size TBI study setting Injury severity (% of total), time
since injury (TSI)
Mean age or
age  SD
Gender
(M/F, %)
Study purpose Self-report
sleep measure
Ayalon et al.10 42 (mild) Long-term community
residence
GCS: 13e15: 100 26 80/20 To describe the physiologic and behavioral
characteristics of circadian rhythm sleep
disorders following mTBI in patients
complaining of insomnia
MEQ
TSI: NI
Baumann et al.27 65 Acute care (hospital) GCS: 13e15: 40 39  17 86/14 To delineate the frequency and clinical
characteristics of sleep/wake disturbances
(SWD) and to assess CSF hypocretin
1 levels 6 mo after TBI
UNS, SNS
9e12: 23
3e8: 37
TSI: 3.3 mo (mean)
Bloomﬁeld et al.39 44 Long-term community
residence
Based on GCS, LOC, PTA 46 86/14 To examine whether poor sleepers post-TBI
had poorer sustained and general attention
functioning than good sleepers post-TBI
PSQI, ISI,
mTBI: 11
modTBI: 21
sTBI: 68
TSI: 71.5 mo
Bushnik et al.11 51 (moderate/
severe)
Inpatient rehab
(medical center)
GSC: NI 31 76/24 To qualify self-reported fatigue and associated
factors during the ﬁrst 2 y after TBI
PSQI, MAF,
FSSTSI: 3 time points: 2.6 mo,
12.6 mo, and 23.2 mo
Chaumet et al.12 36 (severe) Vocational-adjustment
program (rehab
department)
Class by Marshall: 33.2  10.9 78/22 To investigate how fatigue could affect driving
performance in TBI patients
FSS, ESS
Diffuse injury I: 11.1
Diffuse injury II: 52.7
Diffuse injury III: 13.8
Diffuse injury IV: 5.5
TSI: > 6 mo
Englander et al.28 119 (self-report) Long-term community
residence (rehab center)
GCS: NI 40  12 66/34 To deﬁne association between fatigue after TBI
and abnormalities in sleep, mood, cognition,
physical functioning and neuroendocrine axes
MAF, FSS,
PSQITSI: 9  7.6 y
Fichtenberg et al.29 91 Outpatient rehab program
(hospital)
GCS: 13e15: 33 33.8  14.5 59/41 To investigate the relationship between insomnia
and select demographic, injury and psychological
variables in post-acute TBI
PSQI
9e12: 21
3e8: 46%
TSI: 3.3 mo (mean)
Fichtenberg et al.30 91 Outpatient rehab program
(hospital)
GCS: 13e15: 33 33.8  14.5 59/41 To examine the utility and validity of the PSQI for
insomnia screening in post-acute TBI
PSQI, ESS
9e12: 21
3e8: 46
TSI: 3.3 mo (mean)
Fichtenberg et al.31 50 Outpatient rehab program GCS: 13e15: 42 36.5 56/44 To establish the frequency of insomnia in a post-
acute TBI population and to compare it with
insomnia rates among other rehabilitation
outpatients
PSQI
9e12: 18
3e8: 40
TSI: 3.8 mo (mean)
Gosselin et al.23 10 (mild) Long-term community
residence
GCS: 13e15: 100 24.3  6.1 70/30 To investigate the effect of sport-related
concussions (mild TBI) on subjective and
objective sleep quality
PSQI, ESS
TSI: NI
Guilleminault
et al.32
184 (head
trauma pts)
Long-term community
residence
Coma >90 min: 38 M: 39  12.5;
F: 34  8
74/26 To assess objectively hypersomnia after head
trauma and to assess relationship between
head trauma and daytime sleepiness
SDQ, SSS,
ESSLOC < 90 min: 49
Neck trauma: 9
Grogginess: 3
TSI: 15.5  5 y
Kaiser et al.40 20 Surgical intensive care unit GCS: Plac: 8  4 Placebo: 43  19 Placebo:90/10 To assess the effect of daily modaﬁnil on
post-traumatic EDS and fatigue. Prospective,
double-blinded, randomized placebo
controlled pilot study
FSS, ESS
Treat: 7  4
TSI: Plac: 2  1.2 y Treat: 37  9 Treat: 80/20
Treat: 1.8  0.9 y
Kempf et al.33 51 Long-term community
residence
GCS: 13e15: 42 40  16 84/16 To assess the prevalence and characteristics of
post-traumatic SWD 3 y after trauma
ESS, FSS,
UNS, SNS9e12: 22
3e8: 38
TSI: 6 mo
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Kraus et al.22 687 (mild) Long-term community
residence
GCS: 13e15: 100 Age range: 18e34:
59.8%; 35e54:
32.8%; 55e64: 7.4%
64/36 To compare the sequelae of TBI 3 mo post-
injury between mild TBI with the non-head
injury patients
PSQI
TSI: 3 mo
Lee et al.41 30 (mild to
moderate)
Post-acute (hospital) Assessment by McAllister: NI 38.8 80/20 To investigate the effect of methylphenidade
(MPD) and sentraline (SER) compared with
placebo on various neuropsychiatric sequelae
associated with TBI
LSEQ, ESS
TSI: 32.2 days (mean)
Mahmood et al.5 87 Outpatient neuro-rehab
program
GCS: 13e15: 28 33.7 56/44 To examine the relation between sleep
disturbance and neurocognitive ability among
TBI patients
PSQI
9e12: 22
3e8: 50
TSI: 2.3 mo
Masel et al.19 71 Residentional rehab
institute
GCS (reported in 56%): 32  11 62/38 To determine the prevalence, demographic and
causes of EDS in TBI adults and to investigate
the relations between self-report and objective
measures of hypersomnolence
ESS, PSQI
Non-hypersomnia: 6  4
Post-traumatic hypersomnia: 7  5
Hypersomnia with abnormal
indices: 8  5
TSI: 38  60 mo
Ouellet et al.6 14 Long-term community
residence
GCS: mild: 29 30.36  9.67 64/36 To compare subjective and objective measures
(PSG) of sleep in TBI suffering from insomnia
and in control
ISI
Mildemod: 7
Mod: 29
Modesevere: 21
Severe: 14
TSI: 20.96 mo
Ouellet et al.34 452 Long-term community
residence
GCS: 13e15: 59.9 40.2  13.1 65/35 To document the frequency of insomnia
(DSM-IV and ICSD criteria); to identify potential
predictors of insomnia in persons with TBI
ISI, MFI
signiﬁcant
other version
of the ISI
9e12: 23.3
3e8: 37
TSI: 7.8 y
Ouellet et al.26 11 Outpatient rehab center CGS: 3e14, evaluation by
multidisciplinary team,
standard criteria used
27.3 (mean) 54/46 To test the efﬁcacy of CBT (stimulus control, sleep
restriction, cognitive restructuring, sleep hygiene
education and fatigue management) for insomnia
associated with TBI
ISI, MFI,
DBAS, DII
Parcell et al.35 63 Community-based
outpatient
rehab center
GCS: 9.6  0.57 32.5  1.7 57/43 To explore subjective sleep reports from chronic
TBI and to examine the extent and nature of sleep
complaints
ESS
GCS: 12e15: 8
9e12: 13
3e8: 27
varTBI: 14
TSI: 230 days (mean)
Parcell et al.7 10 Inpatient rehab (hospital) GCS: 10.8  1.0 38.8  4.3 60/40 To evaluate changes in sleep quality and
objectively assessed sleep parameters after
TBI and investigate the relationship between these
changes and mood and injury characteristics
PSQI, ESS,
MEQGCS: various: 20
9e12: 40
3e8: 40
TSI: 516  124 days
Rao et al.36 54 Post-acute (community) GCS:13e15: 65 43.2  17.7 59/41 To assess the prevalence of and risk factors for
sleep disturbances in the acute post-traumatic
brain injury period
MOS-sleep
scale9e12: 11
3e8: 19
TSI: >3 mo
Ruff et al.24 74 (mild) Regional polytrauma
center
The criteria for mTBI: LOC <30 min
duration of any alteration in mental
state <24 h, and period of PTA <24 h.
29.4  2.9 93/7 To examine whether 9 weeks of prasozin
(alpha-adrenergic blocking agent, able to block
nightmares) together with sleep hygiene
counseling would improve sleep, headaches
and cognitive performance
ESS
TSI: NI
Shekleton et al.37 23 Inpatient rehab
(hospital)
GCS: 8.8  3.73e14 32.5  12.0 74/26 To investigate sleep/wake disturbances and their
underlying mechanisms in TBI patients sample
PSQI, ESS,
MEQTSI: 429.7  287.6 days
Steele et al.38 10 Outpatient rehab
(hospital)
GCS: 10.9  1.016e14 37.8  4.38 60/40 To investigate sleep timing following TBI using
DLMO and MEQ
MEQ
TSI: 516  124.04 days
Williams et al.21 9 (mild) Long-term community
residence
GCS: 13e15: 100 21.4  2.4 67/33 To characterize the extend and nature of disturbed
sleep after mTBI and to determine whether sleep
disturbances were more psychophysiological,
psychiatric or idiopathic insomnia
PSQI, SDQ,
BSIQTSI: 27.8  15.5 mo
(continued on next page)
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Table 3
Grouping of sleep measures according to type.
Type of Instrument Name of instrument
Generic e quality of sleep Leeds sleep evaluation questionnaire (LSEQ)41
Generic e functioning Medical outcome scale for sleep (MOS)36
Generic e chronotype Morningness-eveningness questionnaire
(MEQ)8,10,37,38
Generic e diagnostic Pittsburgh sleep quality index
(PSQI)5,11,19,21e23,28,29,31,37,39
Generic Sleep disorders questionnaire (SDQ)21,32
Condition-speciﬁc insomnia Brock sleep and insomnia questionnaire
(BSIQ)21
Condition-speciﬁc insomnia e
cognition
Dysfunctional beliefs and attitudes about
sleep scale (DBAS)26
Condition-speciﬁc insomnia Insomnia severity index (ISI)6,26,34,39
Condition-speciﬁc insomnia Diagnostic interview for insomnia (DII)26
Condition-speciﬁc narcolepsy Ullanlinna narcolepsy scale (UNS)27,33
Condition-speciﬁc narcolepsy Swiss narcolepsy scale (SNS)27,33
Symptom e sleepiness Stanford sleepiness scale (SSS)32
Symptom e sleepiness Epworth sleepiness scale
(ESS)8,12,19,23e25,30,32,33,35,37,40,41
Symptom e fatigue Fatigue severity scale (FSS) 11,12,28,33,40
Symptom e fatigue Multidimensional fatigue inventory (MFI-20)6,34
Symptom e fatigue Multidimensional assessment of fatigue
(MAF)11,28
T. Mollayeva et al. / Sleep Medicine Reviews 17 (2013) 411e423418that sleepiness is a basic physiological state and its presence and
severity can be determined by the readiness with which sleep onset
occurs.42 As with other self-reported symptoms, one’s perception
inﬂuences the severity and presentation of the complaint. There
was great variability in the perception of excessive
sleepinessdsome viewed sleepiness as a period of lapses in
attention, others as reduced cognitive ability, the inability to
comprehend information and act quickly, or a reduction in activity.
However, the last of those concepts was more relevant to impaired
alertness.43 According to the studies, it appears to be easier to
perceive a lack of energy than any degree of sleepiness. This often
results in confusion as to the symptoms of fatigue, excessive
sleepiness, and impaired alertness.44 The perception of sleepiness
was also inﬂuenced by the length of the period of sleep deprivation.
Chronically sleep-deprived persons, having adjusted to their
impairment, are less likely to recognize their degree of sleepiness,
despite reporting a lack of energy. Distinguishing excessive sleep-
iness, fatigue, and impaired alertness can be difﬁcult, especially in
the TBI population; however clinical history, and, in research, the
inclusion of additional items/scales to differentiate between the
three symptoms may be helpful in identifying the underlying
pathology.
Quality assessment
The quality of the measures was evaluated using the evidence-
based assessment proposed by Holmbeck et al.20 None of the mea-
sures met the criteria for “well-established,” “approaching well-
established,” or “promising” ratings in a TBI population (Table 1).
While Fichtenberg et al. assessed the concurrent validity of the PSQI,
the reliability of the measure was not reported.30 Similarly, Masel
et al.19 reported the concurrent validity of the ESS and the PSQI
against MSLT scores, but not the reliability. Good validity does not
imply good reliability, and the instrument therefore cannot be
considered as valid in a TBI population without sufﬁcient reliability
data.
Discussion
This systematic review covers the various sleep-related self-
report measures used in TBI research and clinical practice to date.
An extensive search strategy led to the identiﬁcation of 16
T. Mollayeva et al. / Sleep Medicine Reviews 17 (2013) 411e423 419measures from more than 100 currently available in the ﬁeld of
sleep medicine.45 These measures were reviewed and compre-
hensively described (Supplementary Tables S2, S3, S4), providing
potential users with information on what has been utilized and
measured regarding sleep in the TBI population, which can aid in
instrument selection.
Twelve out of the 16measures presented good psychometric data
in the population of people with TBI as well as in other study pop-
ulations, providing an empirical base for further testing of their
psychometric properties in a TBI population. However, when the
PSQI and the ESSwere tested for concurrent validityalongwith other
measures in the TBI population, ﬁndings were inconsistent. Fich-
tenberg et al.30 reported good concurrent validity of the PSQI when
tested against a sleep diary and clinical diagnoses of insomnia.When
Masel et al.19 evaluated the PSQI and the ESS against the MSLT, they
found no signiﬁcant correlations. While this is expected for the
relationship between the PSQI and the MSLT, due to the different
dimensions of the constructs being assessed, the results were un-
expected for the relationship between the ESS and the MSLT, raising
concern about the clinical utility of self-report measures in people
with TBI. Some researchers stressed that severe TBI participants
under-reported changes in their sleep due to impaired self-
awareness or because they did not perceive the sleep disturbance
to be problematic relative to other disabilities.3,37 Others2,5 reported
that milder TBIs were associated with increased self-reported sleep
disturbance, questioning the ability of such measures to properly
assess sleeppost-TBI. Any furtherdiscussion regarding theutilization
of self-report sleep measures must consider how severity/localiza-
tion of injury relates to the changes in awareness that may inﬂuence
the responses of peoplewith TBI.46 A personwithmoderate to severe
TBI, or a personwith TBIwith pre-existing sleep difﬁcultiesmight be
unable to fully grasp the changes to their sleep since the injury, or
report on sleep quality and quantity with sufﬁcient insight. Family
members, caregivers, or other providers might be more helpful in
providing a detailed description of the person’s sleep pattern.
Moreover, individuals with severe TBI who acknowledge their sleep
difﬁcultiesmight not recognize how poor sleep affects their daytime
functioning. In such cases, supplementing self-report sleepmeasures
with reports by a signiﬁcant other should be considered by clinicians
or researchers. Alternatively, individuals with milder TBI might be
more aware of changes in their sleep since the injury, and are more
likely to report these changes.47 Studieshave shown that peoplewith
mild TBI are more likely to report on a range of symptoms.48,49 As
discussed earlier, some researchers observed symptom magniﬁca-
tion in themild TBI group.2,5We therefore propose that one’s level of
awareness or insight may not necessarily be a function of global
cognitive functioning post-TBI, but may be more related to the state
of frontal-executive functioning50,51; however, this dimension was
not studied in the literature discussed in this review. Furthermore,
depressive symptoms, pain, and personality disorders that are pre-
morbid or occur post-injury can contribute to diminished coping
abilities, possibly leading to negative perceptions of sleep qual-
ity.52,53 In this case, the recommended measures would have more
concrete domains that comprehensively assess the different aspects
of sleep quality pre- and post-injury, and explore the complex
symptom interactions in TBI patients, such as pain, psychological
proﬁle, the effect of medications, and comorbid medical conditions.
An appropriate tool always considers the characteristics of the
study/clinical population to be assessed. However, some of the
measures did not capture the unique characteristics of people with
TBI. In the ESS, for example, some items refer to the probability of
falling asleep during driving or sitting in a public place (e.g., theater
or meeting), activities which may not be relevant to a person with
TBI. Answering these items hypothetically may result in inaccurate
scores.Another example is the applicability of the generic MOS sleep
scale, as the lack of items assessing the use of sleep medication and
those related to leg movements, as well as the inability of some
respondents to complete all items, highlight the need for precau-
tion in its application. When researchers utilized the MEQ, they felt
that concepts might have been too abstract for cognitively impaired
persons; furthermore, patients might require a high level of
cognitive ability to think in terms of their “best-feeling rhythm” and
picture how they might feel when asked to engage in exercise at
certain times of the day.10,38 The SDQ and the BSIQ require signif-
icant cognitive and mental demand for completion due to the
quantity of items. As for the SNS, patients might ﬁnd it difﬁcult to
answer questions 4 and 5 (knee buckling and sagging of jaw during
cataplexy) due to the likelihood of motor impairments related to
the injury itself and not to a sleep disorder being screened for.
Thus, in order to ensure that a measure gathers unbiased in-
formation, researchers and clinicians must consider the following
characteristics of TBI persons. First, the cognitive ability of the
person with TBI to understand and respond to the items in the
questionnaire must be considered. This is speciﬁcally relevant to
participants with severe TBI. In such cases, the help of a signiﬁcant
other/caregiver will likely enhance the validity of the responses and
accuracy in reporting on issues such as snoring, bruxism, periodic
leg movements (PLM), sleep talking, etc. Second, measures with
fewer response choices, more concrete items instead of Likert re-
sponses, and using visual analog scales might be more suitable.
Third, the respondent’s ability to recall information over a deﬁned
period of time is vital for consideration; measures with a shorter
recall period are likely to produce more accurate responses. Fourth,
the appropriateness of the measure’s domains and items to the
population being assessed is of great importance, as injury to the
brain often results in considerable changes in functioning, such that
certain physical and social activities referred to in the question-
naires designed for the general population might not be applicable
to a disabled person. Finally, another feature that may impact re-
sponses is the sensitivity of the issue being addressed in the
question. For example, a participant may not honestly report on the
probability of events such as “falling asleep while stopped for a few
minutes in trafﬁc”, fearing the consequences of the admission. The
discussion of the issues encountered with use of self-report mea-
sures in the TBI population in this review is restricted, as none of
the included studies reported on skipped and/or missing items.
In future studies, researchers should consider omission of irrele-
vant or non-applicable items within the utilized self-report mea-
sures and report on such occurrences to provide knowledge users
with information toweigh the advantages and disadvantages of use
of a particular measure in the TBI population.
In this context, prior to the utilization of a self-report measure, it
is important to assess its validity, reliability, and responsiveness in
the TBI population. To date, only two measures have been partially
tested (e.g., concurrent validity) in the population of interest.19,30
This poses a risk to TBI researchers and clinicians regarding inter-
pretation of the results and their ability to rely on self-report scores
when assessing sleep post-TBI. While self-perception is unique and
important, the accuracy of self-reporting remains a challenge. The
current view of many researchers in the ﬁeld of TBI is that objective
and subjective measures should be utilized together in clinical
settings and research studies in the TBI population.2,8,19,23,31
Finally, when selecting a sleep assessment tool from those
available, careful consideration of which domains the measure will
screen, diagnose, or monitor is a priority. In efﬁcacy studies of
treatment intervention, the following are considered most impor-
tant: treatment responsiveness, a continuous measurement scale,
transparency of scoring, broad symptom coverage, overall sum-
mary scoring, and the timeframe of reporting. In drug efﬁcacy
T. Mollayeva et al. / Sleep Medicine Reviews 17 (2013) 411e423420studies, special attention should be paid toward items regarding
symptoms, especially if the medication has side effects resembling
symptoms of sleep impairment (e.g., fatigue, sleepiness), because
their inclusion in a measure will reduce the chances of demon-
strating a treatment effect.54 For observational studies focusing on
population description or analyzing data to ﬁnd risk factors, the
main characteristic of a measure would be its diagnostic speciﬁcity,
as classifying patients accurately is crucial (e.g., the instrument
should be able to differentiate depression-related insomnia from
psychological or primary insomnia54). Given the number of con-
founders associated with poor sleep post-TBI, it is important to
consider inclusion of additional measurements of comorbidities in
order to prevent or minimize confounding effects. Of less impor-
tance are continuous measurement scaling and the transparency of
scoring of the measure.
It is important to conclude our discussion by providing thoughts
on the various applications of self-report sleep measures by re-
searchers and clinicians. Clinicians are traditionally focused on
sleep problem diagnosis and evaluation of symptoms, whereas re-
searchers primarily concentrate on the determinants and conse-
quences of poor sleep. Although standardized self-report measures
can assist in clinical decision-making, they are rarely used in clinical
practice, mainly as primary outcomes in clinical trials. The reasons
for this gap between research and clinical practice is complex, and
goes beyond the scope of this review; however, it may be related to
the clinicians’ lack of familiarity with self-report sleep measures
available in the ﬁeld, the large discrepancy observed between
symptom burden rated by physician and patient, and most impor-
tantly, the lack of acceptance of the feasibility of self-report mea-
sures in assisting in clinical decision-making. However, a self-report
sleep measure has the potential to directly promote patient-
centered care if scales related to symptom burden, sleep function,
and the impact of sleep on health outcomes (e.g., daytime func-
tioning, community integration, quality of life) are incorporated
into an instrument, in which case, the use of a self-report measure
can support more informed clinical decision-making. For clinicians,
the issues of sensitivity and practicality are attracting increasing
attention. If a measure has just two categories (e.g., “yes” and “ no”),
it lacks sensitivity, as it cannot reﬂect ﬁne distinctions in sleep
quality or be used to recordminor, but clinically signiﬁcant changes.
The practicality of the instrument, which is related to administra-
tion burden and analysis, as well as direct clinical interpretation of
the scores (e.g., likelihood measures and visual scales preferable
over numerical scores) are preferable in clinical practice. Measures
such as the SDQ, BSIQ, and the DIImay not suit a clinician, due to the
large number of items impeding completion time. On the other
hand, the PSQI, requiring less than 5 min to complete, can be
administered to a patient in the waiting room. Furthermore, visual
analog scales such as the DBAS and LSEQ do not require score
calculation and can be of immediate use to the clinician when
assessing their patient. Despite their potential beneﬁts, before self-
reported measures can be implemented into TBI clinical practice,
research should focus on further evaluating the psychometric
properties of measures developed for other study populations,
which is a point of convergence for clinicians and researchers. This
review serves as an introduction to the applicability of self-report
sleep measures to the TBI population and is intended to comple-
ment the current clinical toolbox, with the goal of improving the
quality of care provided to persons with brain injuries.
Limitations
Certain features of this review are open to debate. First, the lan-
guage limitation in our literature search may not have identiﬁed all
non-English measures. Second, all of the articles included in thisreview were peer-reviewed and, as such, there is a publication bias.
Third, not all studies that focused on fatigue were included in this
review. To be consistent with our inclusion criteria, we incorporated
only those in which researchers mainly focused on sleep, or
attempted to discriminate fatigue from sleepiness. A further limita-
tion applies to the way the data was presented. In order to be
concise, purpose groups and the psychometric properties of each
measure were not reported in great detail. Although we have
attempted to ﬁnd all relevant articles on the psychometric properties
of the extracted measures, it is possible some studies were missed.
Finally, we excluded analysis of sleep diaries in this review,
despite their frequency of use by researchers,6,7,27,28,30,35 and their
potential in assessing sleep quality and quantity post-TBI. We
decided this because few standardized sleep diaries are available
(e.g., Karolinska sleep diary, Pittsburgh sleep diary), and none have
been applied in the TBI population.
Furthermore, in the literature cited in this review, the sleep
diary format varied. Scoring also varied, and results were generally
applied toward a clinical diagnosis of insomnia and quantiﬁcation
of sleep and waking behavior over a speciﬁc period of time (usually
2e4 weeks). The strength of the instrument was its ability to pro-
spectively depict sleep and daytime functioning over a period of
time. However, the low return rates of diaries, response burden,
possible impaired judgment, and common sleep state mispercep-
tion in the TBI population warrants careful interpretation of results
and accuracy.
Although this review was meant to shed light on how sleep
dysfunction is currently measured in TBI research and clinical
practice, and applied a broad search strategy, some existing mea-
sures were not included, as the studies in which they were utilized
did not meet the inclusion criteria for this review (e.g., the study
utilized an adjusted measure, focused on different topic). Despite
these limitations, this review is the ﬁrst to comprehensively assess
self-report measures applied to evaluate sleep dysfunction in per-
sons with TBI.
Conclusions
This systematic review demonstrates that although impaired
sleep is highly prevalent in the TBI population, no instrument has
been speciﬁcally developed for assessing sleep in adults with TBI.
Moreover, despite a number of standardized measures utilized,
only the PSQI and ESS have been validated against other sleep
measures in a TBI sample. Currently, the ﬁeld of TBI requires further
testing of the existing self-report measures whose psychometric
properties were described in other target populations, taking into
account medication side effects, pain, anxiety, and depression,
which may confound the outcome of sleep measures developed for
the general population. With this, it is necessary and timely to
design a new sleep instrument that would consider history, dura-
tion, and severity of sleep complaints and could be completed by a
patient with the help of a family member/caregiver. This instru-
ment should also report the consequences of the patient’s poor
sleep (e.g., impaired daytime functioning), include items to delin-
eate themost common confounders, and feature items/scale for the
most common sleep disorders. When and if a new measure is
developed, before being used in research or clinical practice, the
instrument should be assessed for its psychometric properties (e.g.,
reliability, validity, and responsiveness) in the TBI population across
levels of injury severity. Even with a validated self-report measure,
the utility of PSG should be considered for the diagnosis of speciﬁc
sleep disorders (e.g., narcolepsy, sleep apnea, REM behavior disor-
der (RBD), PLM, erectile dysfunction after TBI, non-REM para-
somnia, nocturnal seizures), which could not be fully diagnosed
using only a self-report measure.
Practice points
 Of the 16 measures reviewed, none met the criteria for
“well- established”, “approaching well- established” or
“promising” in a TBI population. Across categories,
many measures have demonstrated good psychomet-
ric properties in other study populations, providing an
evidence base for their validation in TBI samples.
 Two studies reported on validity in TBI subjects. The
PSQI was shown to have good concurrent validity when
tested against sleep diary and clinical diagnoses of
insomnia. When ESS and PSQI were compared with
MSLT scores, no significant correlation was found.
 Several researchers stated under-/over-reported sleep
disturbances by TBI participants and recommended
self-report and objective instruments to be utilized
together.
 Consideration of cognitive level and the relevance of
the items in the choice of measure are important.
 Minimizing respondent burden by selecting shorter in-
strumentsmay bemore appropriate in TBI research and
as a screening instrument in clinical practice.
 The input of the significant other/caregiver may
enhance the validity of the self-report.
 When selecting a self-report sleep measure, the do-
mains the measure will screen, diagnose or monitor
should be considered.
Research agenda
 No instrument has been developed for assessing sleep
post-TBI. Development of a new instrument which
would consider specifics of the TBI population with a
version for significant other/caregiver is a key for future
direction.
 All but two measures have no data on psychometric
properties in the TBI population. Further studies
focusing of psychometric evaluation will provide
greater insight into the utility of existing measures in
TBI populations.
 The utility of polysomnography and actigraphy should
be kept open in TBI population for the diagnosis of
specific sleep disorders, which may not be fully
captured by a self-report measure only.
* The most important references are denoted by an asterisk.
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